Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

Rhea-AI Summary

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, has announced it will report its financial results for the third quarter of 2024 on Wednesday, October 30, 2024, after market close. The company will host a conference call at 2 PM Pacific Time (5 PM Eastern Time) on the same day to discuss the results.

Interested parties can participate in the call by dialing 800-579-2543 within the U.S. or 785-424-1789 outside the U.S., using the access code: BIORAD. Additionally, a live webcast of the conference call will be available in the "Investor Relations" section of Bio-Rad's website under "Events & Presentations" at investors.bio-rad.com. A replay of the webcast will be accessible for up to one year.

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the third quarter of 2024 on Wednesday, October 30, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

To participate, dial 800-579-2543 within the U.S. or 785-424-1789 outside the U.S., access code: BIORAD. A live webcast of the conference call will also be available in the "Investor Relations" section of the company’s website under "Events & Presentations" at investors.bio-rad.com. A replay of the webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241014119743/en/

Investor Contact:

Edward Chung, Investor Relations

510-741-6104

ir@bio-rad.com

Media Contact:

Anna Gralinska, Corporate Communications

510-741-6643

cc@bio-rad.com

Source: Bio-Rad Laboratories, Inc.

FAQ

When will Bio-Rad (BIO) report its Q3 2024 financial results?

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) will report its financial results for the third quarter of 2024 on Wednesday, October 30, 2024, after the market closes.

How can investors participate in Bio-Rad's Q3 2024 earnings call?

Investors can participate in Bio-Rad's Q3 2024 earnings call by dialing 800-579-2543 within the U.S. or 785-424-1789 outside the U.S., using the access code: BIORAD. The call is scheduled for 2 PM Pacific Time (5 PM Eastern Time) on October 30, 2024.

Will there be a webcast available for Bio-Rad's Q3 2024 earnings call?

Yes, a live webcast of Bio-Rad's Q3 2024 earnings call will be available in the "Investor Relations" section of the company's website under "Events & Presentations" at investors.bio-rad.com. A replay of the webcast will be accessible for up to one year.